Showing results (121-130 of 880) with videos related to
Sort By:
Pageof 88
PHAGE (New Rochelle, N.Y.)|May 14, 2026
Disruption in the Host-Phage Dynamics and Altered Microbial Diversity in the Upper Respiratory Tract of SARS-CoV-2-Infected IndividualsSiddharth Singh Tomar, Krishna KhairnarClinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 5, 2013
Primary sclerosing cholangitis: diagnosis, prognosis, and managementSiddharth Singh, Jayant A TalwalkarGastroenterology Clinics of North America|August 12, 2014
Update on anti-tumor necrosis factor agents in Crohn diseaseSiddharth Singh, Darrell S PardiFrontiers in Public Health|July 13, 2023
Challenges of SARS-CoV-2 genomic surveillance in India during low positivity rate scenarioSiddharth Singh Tomar, Krishna KhairnarInflammatory Bowel Diseases|May 3, 2016
A Biomarker Panel to Detect Synchronous Neoplasm in Non-neoplastic Surveillance Biopsies from Patients with Ulcerative ColitisMegan M Garrity-Park, Edward V Loftus, Sandra C Bryant, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 18, 2017
Non-Clostridium difficile Bacterial Infections Are Rare in Patients With Flares of Inflammatory Bowel DiseaseYuri Hanada, Sahil Khanna, Edward V Loftus, et al.The American Journal of Gastroenterology|October 9, 2023
Effectiveness and Safety of Antiobesity Medications in Patients With Obesity and Inflammatory Bowel DiseaseJonathan T Pham, Wissam Ghusn, Andres Acosta, et al.Hepatology International|December 28, 2020
Factors associated with major radiological progression of primary sclerosing cholangitis in patients with inflammatory bowel diseaseNahla Azzam, Yazed AlRuthia, Othman Alharbi, et al.Intestinal Research|February 5, 2020
Biosimilars: concept, current status, and future perspectives in inflammatory bowel diseasesSang Hyoung Park, Jae Cheol Park, Milan Lukas, et al.Inflammatory Bowel Diseases|June 12, 2014
Treatment patterns, complications, and disease relapse in a real-world population of patients with moderate-to-severe ulcerative colitis initiating immunomodulator therapyEdward V Loftus, Keith L Davis, Chi-Chuan Wang, et al.Pageof 88